Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders

INTRODUCTION: To prospectively determine the diagnostic value of cerebrospinal fluid (CSF) levels total-tau (tau) to amyloid-β(1–42) ratio (Aβ(1–42)) ratio (tau/Aβ(1–42) ratio), phosphorylated-tau (p-tau) to tau ratio (p-tau/tau ratio), neurofilament light chain (NfL) and YKL40 in the late-onset fro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Vijverberg, Everard G.B., Dols, Annemiek, Krudop, Welmoed A., Del Campo Milan, Marta, Kerssens, Cora J., Gossink, Flora, Prins, Niels D., Stek, Max L., Scheltens, Philip, Teunissen, Charlotte E., Pijnenburg, Yolande A.L.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2017
Matèries:
Special Section: Neuropsychiatric Contributions to Alzheimer's Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352718/
https://ncbi.nlm.nih.gov/pubmed/28337476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.01.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars